4D Molecular Therapeutics, Inc. Quarterly Assets in USD from Q4 2019 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: 4D Molecular Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2019 to Q3 2024.
4D Molecular Therapeutics, Inc. Assets for the quarter ending September 30, 2024 was $604M, a 67% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$604M	+$242M	+67%	Sep 30, 2024	10-Q	2024-11-13
Q2 2024	$620M	+$268M	+75.9%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$630M	+$386M	+158%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$340M	+$78M	+29.8%	Dec 31, 2023	10-Q	2024-11-13
Q3 2023	$362M	+$81.4M	+29.1%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$353M	+$49.6M	+16.4%	Jun 30, 2023	10-Q	2023-08-09
Q1 2023	$244M	-$80.9M	-24.9%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$262M	-$91.6M	-25.9%	Dec 31, 2022	10-K	2024-02-29
Q3 2022	$280M	+$39.5M	+16.4%	Sep 30, 2022	10-Q	2022-11-08
Q2 2022	$303M	+$48M	+18.8%	Jun 30, 2022	10-Q	2022-08-11
Q1 2022	$325M	+$54.8M	+20.3%	Mar 31, 2022	10-Q	2022-05-12
Q4 2021	$353M	+$65.2M	+22.6%	Dec 31, 2021	10-K	2023-03-15
Q3 2021	$241M			Sep 30, 2021	10-Q	2021-11-10
Q2 2021	$255M			Jun 30, 2021	10-Q	2021-08-12
Q1 2021	$270M			Mar 31, 2021	10-Q	2021-05-13
Q4 2020	$288M	+$230M	+395%	Dec 31, 2020	10-K	2022-03-28
Q4 2019	$58.2M			Dec 31, 2019	10-K	2021-03-25

* An asterisk sign (*) next to the value indicates that the value is likely invalid.